Emerging Neurodegenerative and Cardiovascular Biomarkers Fuel Growth in Specialized U.S. Segments
The U.S. biomarkers market was valued at USD 25.92 billion in 2024, with a projected CAGR of 15.16% expected from 2025 to 2034, driven by strong national policy impact, robust R&D leadership, and strategic positioning of leading global players. The U.S. remains the epicenter of biomarker innovation, supported by federal funding from agencies such as the National Institutes of Health (NIH),...
0 Reacties 0 aandelen 76 Views 0 voorbeeld
Watachat https://watachat.com